Q2 2018 Holdings
Filed 2018-08-14 | 10 holdings | $134.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc.(BIIB) | COM | 09062X103 | $134.0M | 461,858 | 99.7% |
| Abbvie Inc.(ABBV) | COM | 00287Y109 | $92.0K | 1,000 | 0.1% |
| Medicines Co. | COM | 584688105 | $70.5K | 1,922,000 | 0.1% |
| Ironwood Pharmaceuticals Inc.(IRWD) | COM CL A | 46333X108 | $64.4K | 3,367,100 | 0.0% |
| Innoviva Inc.(INVA) | COM | 45781M101 | $62.6K | 4,535,000 | 0.0% |
| Allergan PLC | SHS | G0177J108 | $57.4K | 344,000 | 0.0% |
| Intercept Pharmaceuticals Inc.(ICPTUSD) | COM | 45845P108 | $53.3K | 635,300 | 0.0% |
| Shire PLC | SPONSORED ADR | 82481R106 | $52.2K | 309,000 | 0.0% |
| Novelion Therapeutics Inc. | COM NEW | 67001K202 | $3.8K | 1,025,000 | 0.0% |
| Apricus Biosciences Inc. | COM NEW | 03832V307 | $564 | 1,447,906 | 0.0% |